ZTOX Insights

CHASBRT

CHASBRT

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Chase Bright Steel (CHASBRT): Board Meeting

Board Meeting Pursuant to the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board at its meeting held today i.e. on May 29, 2026, approved the Audited Financial Results of the Company for the quarter and year ended 31st March, 2026. The Results along with the Audit Report, declaration on unmodified opinion on Auditor's Report are attached for records. The Board Meeting commenced at 05:30 p.m. and concluded at 6:30 p.

Read article

CHASBRT

CHASBRT

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Chase Bright Steel (CHASBRT): Board Meeting

Board Meeting Pursuant to the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board at its meeting held today i.e. on May 29, 2026, approved the Audited Financial Results of the Company for the quarter and year ended 31st March, 2026. The Results along with the Audit Report, declaration on unmodified opinion on Auditor's Report are attached for records. The Board Meeting commenced at 05:30 p.m. and concluded at 6:30 p.

Read article

CONCORDBIO

CONCORDBIO

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Corp. Action

Corp. Action The Board has recommended dividend of Rs. 7.55 per equity share of face value of Rs. 1 each fully paid up for the Financial Year 2025-26. The Board has recommended dividend of Rs. 7.55 per equity share of face value of Rs. 1 each fully paid up for the Financial Year 2025-26.

Read article

CONCORDBIO

CONCORDBIO

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Corp. Action

Corp. Action The Board has recommended dividend of Rs. 7.55 per equity share of face value of Rs. 1 each fully paid up for the Financial Year 2025-26. The Board has recommended dividend of Rs. 7.55 per equity share of face value of Rs. 1 each fully paid up for the Financial Year 2025-26.

Read article

CONCORDBIO

CONCORDBIO

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Corp. Action

Corp. Action The Board has recommended dividend of Rs. 7.55 per equity share of face value of Rs. 1 each fully paid up for the Financial Year 2025-26. The Board has recommended dividend of Rs. 7.55 per equity share of face value of Rs. 1 each fully paid up for the Financial Year 2025-26.

Read article

DDIL

DDIL

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Deep Health AI India (DDIL): Company Update

Company Update Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith the Statement of Deviation and variation for the Quarter and year ended March 31, 2026, and the detailed statement in relation to the same is enclosed as 'Annexure A'. Further, this is to inform you that the Rights Issue proceeds have been fully utilized during the quarter ended on March 31, 2026. Therefore, the filing of statement of de

Read article

DDIL

DDIL

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Deep Health AI India (DDIL): Company Update

Company Update Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith the Statement of Deviation and variation for the Quarter and year ended March 31, 2026, and the detailed statement in relation to the same is enclosed as 'Annexure A'. Further, this is to inform you that the Rights Issue proceeds have been fully utilized during the quarter ended on March 31, 2026. Therefore, the filing of statement of de

Read article

DDIL

DDIL

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Deep Health AI India (DDIL): Company Update

Company Update Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith the Statement of Deviation and variation for the Quarter and year ended March 31, 2026, and the detailed statement in relation to the same is enclosed as 'Annexure A'. Further, this is to inform you that the Rights Issue proceeds have been fully utilized during the quarter ended on March 31, 2026. Therefore, the filing of statement of de

Read article

JUBLPHARMA

JUBLPHARMA

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Jubilant Pharmova (JUBLPHARMA): General Updates

General Updates Jubilant Pharmova Limited has informed the Exchange about General Updates - USFDA Inspection Update - Contract manufacturing facility at Montreal, Canada Jubilant Pharmova Limited has informed the Exchange about General Updates - USFDA Inspection Update - Contract manufacturing facility at Montreal, Canada Jubilant Pharmova Limited has informed the Exchange about General Updates - USFDA Inspection Update - Contract manufacturing facility at Montreal, Canada

Read article

JUBLPHARMA

JUBLPHARMA

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Jubilant Pharmova (JUBLPHARMA): General Updates

General Updates Jubilant Pharmova Limited has informed the Exchange about General Updates - USFDA Inspection Update - Contract manufacturing facility at Montreal, Canada Jubilant Pharmova Limited has informed the Exchange about General Updates - USFDA Inspection Update - Contract manufacturing facility at Montreal, Canada Jubilant Pharmova Limited has informed the Exchange about General Updates - USFDA Inspection Update - Contract manufacturing facility at Montreal, Canada

Read article

NHPC

NHPC

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

NHPC (NHPC): Company Update

Company Update In compliance to Regulation 30 of SEBI LODR, issue of AI Series Bonds 2041 on private placement basis is submitted. The other details is given in the attached letter. In compliance to Regulation 30 of SEBI LODR, issue of AI Series Bonds 2041 on private placement basis is submitted. The other details is given in the attached letter. In compliance to Regulation 30 of SEBI LODR, issue of AI Series Bonds 2041 on private placement basis is submitted. The other details is given in th

Read article

NHPC

NHPC

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

NHPC (NHPC): Company Update

Company Update In compliance to Regulation 30 of SEBI LODR, issue of AI Series Bonds 2041 on private placement basis is submitted. The other details is given in the attached letter. In compliance to Regulation 30 of SEBI LODR, issue of AI Series Bonds 2041 on private placement basis is submitted. The other details is given in the attached letter. In compliance to Regulation 30 of SEBI LODR, issue of AI Series Bonds 2041 on private placement basis is submitted. The other details is given in th

Read article

NHPC

NHPC

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

NHPC (NHPC): Company Update

Company Update In compliance to Regulation 30 of SEBI LODR, change in Senior Management Personnel (one level below the Board) is submitted. The details given in the attached letter. In compliance to Regulation 30 of SEBI LODR, change in Senior Management Personnel (one level below the Board) is submitted. The details given in the attached letter. In compliance to Regulation 30 of SEBI LODR, change in Senior Management Personnel (one level below the Board) is submitted. The details given in th

Read article